Table 4 Gender-dependent adherence to general cardio-preventive criteria
From: Sex-specific-differences in cardiometabolic risk in type 1 diabetes: a cross-sectional study
Criteria | Adherence (%) [95% Cl] | |
|---|---|---|
| Â | Men | Women |
| Â | n=123 | n=102 |
High level of adherence to general cardio-preventive measures | Â | |
• Patient with apparent contraindication/intolerance to aspirin therapy is prescribed clopidogrel 75 mg | 100 | 100 |
• Prescribing of angiotensin-converting enzyme inhibitors (ACE-Is) or angiotensin II receptor blockers (ARBs) post myocardial infarction | 100 | 100 |
• Prescribing of beta-blocker in post myocardial infarction patients or in patients with coronary heart disease | 68.8 [56.7-80.9] | 88.0* [76.1-97.9] |
• Prescribing of ACE-I/ARB in patients with microalbuminuria/proteinuria | 76.1 [63.8-88.4] | 75.7 [61.9-89.5] |
Intermediate level of adherence to general cardio-preventive measures | Â | Â |
• Patient aged ≥40 years is prescribed a statin when pretreatment serum cholesterol was ≥200 mg/dl | 67.4 [57.7-77.2] | 60.9 [50.7-71.2] |
Low level of adherence to general cardio-preventive measures | Â | Â |
• Patient who is described a statin has achieved a triglyceride level of 350 mg/dl and LDL level of 80 mg/dl | 40.3 [28.1-52.5] | 19.6** [4.0-24.8] |
• Patient aged ≥50 years is prescribed aspirin | 53.4 [42.0-64.9] | 37.1* [25.8-48.5] |
• Patients aged <50 years with cardiovascular risk factors is prescribed aspirin | 5.9 [0–17.1] | 0 |
• Patient who continues to smoke has been offered smoking cessation advice which involves structured behavioural support plus nicotine replacement therapy or bupropion/varenicline | 0 | 0 |